These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 27865854)
1. Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation. Zhang DG; Zhang C; Wang JX; Wang BW; Wang H; Zhang ZH; Chen YH; Lu Y; Tao L; Wang JQ; Chen X; Xu DX Toxicol Appl Pharmacol; 2017 Jan; 314():39-47. PubMed ID: 27865854 [TBL] [Abstract][Full Text] [Related]
2. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation. Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575 [TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury. Zhu JB; Xu S; Li J; Song J; Luo B; Song YP; Zhang ZH; Chen YH; Xie DD; Yu DX; Xu DX Eur J Pharmacol; 2018 Nov; 838():60-68. PubMed ID: 30196109 [TBL] [Abstract][Full Text] [Related]
4. Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3. Fan YY; Ding W; Zhang C; Fu L; Xu DX; Chen X Int Immunopharmacol; 2019 Dec; 77():105911. PubMed ID: 31671330 [TBL] [Abstract][Full Text] [Related]
5. Obeticholic acid differentially regulates hepatic injury and inflammation at different stages of D-galactosamine/lipopolysaccharide-evoked acute liver failure. Ding W; Fan YY; Zhang C; Fu L; Chen X; Xu DX Eur J Pharmacol; 2019 May; 850():150-157. PubMed ID: 30772394 [TBL] [Abstract][Full Text] [Related]
6. Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity. Chen YH; Hu XG; Zhou Y; Yu Z; Fu L; Zhang GB; Bo QL; Wang H; Zhang C; Xu DX J Immunol; 2016 Dec; 197(12):4762-4770. PubMed ID: 27821667 [TBL] [Abstract][Full Text] [Related]
7. Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice. Fei J; Fu L; Hu B; Chen YH; Zhao H; Xu DX; Li JB Int Immunopharmacol; 2019 Jan; 66():177-184. PubMed ID: 30468885 [TBL] [Abstract][Full Text] [Related]
8. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid. Ijssennagger N; Janssen AWF; Milona A; Ramos Pittol JM; Hollman DAA; Mokry M; Betzel B; Berends FJ; Janssen IM; van Mil SWC; Kersten S J Hepatol; 2016 May; 64(5):1158-1166. PubMed ID: 26812075 [TBL] [Abstract][Full Text] [Related]
11. Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice. Wu H; Liu G; He Y; Da J; Xie B Eur J Pharmacol; 2019 Sep; 858():172393. PubMed ID: 31085240 [TBL] [Abstract][Full Text] [Related]
12. Methane alleviates carbon tetrachloride induced liver injury in mice: anti-inflammatory action demonstrated by increased PI3K/Akt/GSK-3β-mediated IL-10 expression. Yao Y; Wang L; Jin P; Li N; Meng Y; Wang C; Xu M; Zhang Y; Bian J; Deng X J Mol Histol; 2017 Aug; 48(4):301-310. PubMed ID: 28597201 [TBL] [Abstract][Full Text] [Related]
13. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats. Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655 [TBL] [Abstract][Full Text] [Related]
14. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway. Ma JQ; Ding J; Zhang L; Liu CM Environ Toxicol Pharmacol; 2014 May; 37(3):975-83. PubMed ID: 24727148 [TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway. Zhang T; Feng S; Li J; Wu Z; Deng Q; Yang W; Li J; Pan G Arch Toxicol; 2022 Jun; 96(6):1829-1843. PubMed ID: 35267068 [TBL] [Abstract][Full Text] [Related]
16. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice. Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208 [TBL] [Abstract][Full Text] [Related]
17. The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride. Wu S; Yang C; Xu N; Wang L; Liu Y; Wang J; Shen X Dig Dis Sci; 2017 Jun; 62(6):1537-1549. PubMed ID: 28365917 [TBL] [Abstract][Full Text] [Related]